Mike Tung | Investor Relations |
Enrique Conterno | Chief Executive Officer |
Peony Yu | Chief Medical Officer |
Chris Chung | Senior Vice President, China Operations |
Elias Kouchakji | Senior Vice President, Clinical Development, Drug Safety and Pharmacovigilance |
Pat Cotroneo | Chief Financial Officer |
Michael Yee | Jefferies |
Geoffrey Porges | SVB Leerink |
Andy Hsieh | William Blair |
Joel Beatty | Citi |
Paul Choi | Goldman Sachs |
Difei Yang | Mizuho Securities |
Ladies and gentlemen, thank you for standing by. And welcome to the FibroGen Fourth Quarter and Full Year 2019 Conference Call. At this time, all participant lines are in a listen-only mode. After the speaker’s presentation, there will be question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.